Literature DB >> 33190733

Unexplored horizons of cDC1 in immunity and tolerance.

Sreekumar Balan1, Kristen J Radford2, Nina Bhardwaj3.   

Abstract

Dendritic cells are a specialized subset of hematopoietic cells essential for mounting immunity against tumors and infectious disease as well as inducing tolerance for maintenance of homeostasis. DCs are equipped with number of immunoregulatory or stimulatory molecules that interact with other leukocytes to modulate their functions. Recent advances in DC biology identified a specific role for the conventional dendritic cell type 1 (cDC1) in eliciting cytotoxic CD8+ T cells essential for clearance of tumors and infected cells. The critical role of this subset in eliciting immune responses or inducing tolerance has largely been defined in mice whereas the biology of human cDC1 is poorly characterized owing to their extremely low frequency in tissues. A detailed characterization of the functions of many immunoregulatory and stimulatory molecules expressed by human cDC1 is critical for understanding their biology to exploit this subset for designing novel therapeutic modalities against cancer, infectious disease and autoimmune disorders.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDCA3; Clec9a; ENPP1; IFN-III; XCR1; cDC1; dendritic cell

Mesh:

Year:  2020        PMID: 33190733     DOI: 10.1016/bs.ai.2020.10.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  4 in total

Review 1.  Therapeutic cancer vaccines.

Authors:  Mansi Saxena; Sjoerd H van der Burg; Cornelis J M Melief; Nina Bhardwaj
Journal:  Nat Rev Cancer       Date:  2021-04-27       Impact factor: 60.716

2.  Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.

Authors:  Raquel S Laureano; Jenny Sprooten; Isaure Vanmeerbeerk; Daniel M Borras; Jannes Govaerts; Stefan Naulaerts; Zwi N Berneman; Benoit Beuselinck; Kalijn F Bol; Jannie Borst; An Coosemans; Angeliki Datsi; Jitka Fučíková; Lisa Kinget; Bart Neyns; Gerty Schreibelt; Evelien Smits; Rüdiger V Sorg; Radek Spisek; Kris Thielemans; Sandra Tuyaerts; Steven De Vleeschouwer; I Jolanda M de Vries; Yanling Xiao; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2022-07-04       Impact factor: 7.723

3.  Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.

Authors:  Athanasios Papadas; Gauri Deb; Alexander Cicala; Adam Officer; Chelsea Hope; Adam Pagenkopf; Evan Flietner; Zachary T Morrow; Philip Emmerich; Joshua Wiesner; Garrett Arauz; Varun Bansal; Karla Esbona; Christian M Capitini; Kristina A Matkowskyj; Dustin A Deming; Katerina Politi; Scott I Abrams; Olivier Harismendy; Fotis Asimakopoulos
Journal:  Cell Rep       Date:  2022-08-16       Impact factor: 9.995

4.  Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer.

Authors:  Raphaël Mattiuz; Carine Brousse; Marc Ambrosini; Jean-Charles Cancel; Gilles Bessou; Julie Mussard; Amélien Sanlaville; Christophe Caux; Nathalie Bendriss-Vermare; Jenny Valladeau-Guilemond; Marc Dalod; Karine Crozat
Journal:  Clin Transl Immunology       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.